13F HOLDINGS REPORT
DCVC Opportunity Fund II GP, LLC
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001104659-26-015687
Total Value
$16.6M
Positions
2
Other Managers
0
Confidential Omitted
No
Holdings (2)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Recursion Pharmaceuticals, Inc. | RXRX | 3,951,141 | $16.2M | 97.42% |
| 2 | IonQ, Inc. | IONQ-WT | 9,521 | $427,207 | 2.58% |